SAN DIEGO—Armed with last month’s FDA approval, Sobi is rolling out its newly minted rare disease drug Gamifant with a small, targeted sales force, and Monday it unveiled more of the data that won the agency’s favor in the first place. In a phase 2/3 trial of Gamifant in primary haemophagocytic lymphohistiocytosis (HLH), 64.7% of… Read More »
Losing weight is hard work, but many people who have lost weight may agree that keeping it off can be an even greater challenge. A lack of self-control or a few too many dietary indulgences are often cited as reasons for regaining weight. But a new study in the November issue of BMJ questions this… Read More »
What do our patients really want from us? When a patient calls up to schedule an appointment, or sends us a message through the patient portal, or calls our front desk staff to leave a message, what is it that they’re looking for? I think, more than anything else, our patients are looking to us… Read More »
Dive Brief: Breaches of protected health information can seriously harm an organization’s brand and finances, but little is known about how breaches occur and the steps organizations take to prevent a recurrence, according to a research letter in JAMA Internal Medicine. The researchers analyzed 1,138 breach cases that occurred between Oct. 21, 2009, and Dec. 31,… Read More »